29 research outputs found
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience
UTILISATION DE LA SPECTROSCOPIE DE PERTES D'ÉNERGIE D'ÉLECTRONS À L'IDENTIFICATION DE DÉPÔTS INTRA-RÉNAUX
La technique de microanalyse par spectroscopie de pertes d'énergie d'électrons est utilisée pour l'identification chimique de divers types de dépots intra-rénaux. Elle a permis la détection de dépôts de béryllium, de silicium, d'iode, de fer et d'argent.Microanalysis by EELS has been used for the elemental identification of urinal deposits identification observed in fine pathological kidney sections. The technique has allowed the detection of béryllium, silicium, iodine, iron and silver deposits
The potential use of cellophane test strips for the quick determination of food colours
Pregnancy and primary Sjögren’s syndrome: management and outcomes in a multicentre retrospective study of 54 pregnancies
Reducing medication errors at admission: 3 cycles to implement, improve and sustain medication reconciliation
The clinical and laboratory manifestations profile of antiphospholipid syndrome among Saudi Arabia population: Examining the applicability of Sapporo criteria
Effects of Immobilization and Permeabilization Procedures on Growth of Chenopodium rubrum Cells and Amaranthin Concentration
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
International audienceBackground. Acquired thrombotic thrombocytopenic purpura is still associated with a 10-20% death rate. So far, early prognostic factors of death could not be clearly identified. To identify prognostic factors associated with 1-month death in thrombotic thrombocytopenic purpura patients with acquired severe (=10N. A 3-level risk score for early death was defined and confirmed in the validation cohort using these variables, with higher values corresponding to increased risk of early death.Conclusions. A risk score for early death was defined in patients with thrombotic thrombocytopenic purpura and validated on an independent cohort. This score should help to stratify early treatment and intensify patients with a worse prognosis